Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    12413371 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women
Conditions: Menopause;   Cognitive Disturbances
Interventions: Drug: atomoxetine;   Drug: placebo

Indicates status has not been verified in more than two years